Onesource Specialty Pharma Ltd.

₹1,508

-13.6 (-0.9%)

ONESOURCE Share Price

Pharmaceuticals & Biotechnology

As on October 1, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 17,312.9 Cr

P/E Ratio-234.2

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,556.26	Bearish
10-DMA	1,575.46	Bearish
20-DMA	1,572.01	Bearish
50-DMA	1,574.23	Bearish
100-DMA	1,640.55	Bearish
200-DMA	1,576.6	Bearish

Historical Performance

1 Year

-15.6%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	14,216	14,449	1,719	387	1,282
Total Expenditure	11,488	9,811	2,602	1,994	1,322
Other Income	465	202	42	27	37
Operating Profit	3,192	4,840	-840	-1,580	-3
Interest	1,222	1,663	894	475	465
Depreciation	2,791	2,739	763	657	531
Profit Before Tax	-920	-671	-3,657	-4,156	-999
Consolidated Net Profit	-738	-180	-3,912	-7,998	-2,312
Adjusted EPS	-6	-2	-98	-199	-76

Compounded Sales Growth

10 Years:61.8

5 Years:61.8

3 Years:105.6

TTM:-0.3

Compounded Profit Growth

10 Years:-20.4

5 Years:-20.4

3 Years:-37.9

TTM:32.6

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:-16.5

Return on Equity

10 Years:N/A

5 Years:-76.1

3 Years:-97.5

last year:-6.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	115	114	40	40	30
Total Reserves	58,132	58,569	3,838	7,755	10,094
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	9,368	5,561	2,823	3,581	6,212
Other Current Liabilities	4,762	4,781	5,357	5,729	5,590
Short Term Borrowings	5,764	4,360	95	1,939	1,839
Total Liabilities	82,221	75,502	13,086	20,088	24,424
Capital Work in Progress	3,139	604	427	1,912	678
Long Term Loans & Advances	2,270	1,208	770	822	2,104
Currents Investments	55	89	158	45	---
Short Term Loans and Advances	1,771	1,622	257	60	113
Total Current Assets	14,380	10,862	1,764	2,284	5,111
Total Assets	82,221	75,502	13,086	20,088	24,424
Adjusted Book Value	508	513	97	194	333

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -234.2, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -11.8%, indicating poor shareholder returns.
The stock carries a low beta of -0.2, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹3192 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹14216 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 835040.7

No. of Shares: 554 (Approx)

Performance:-16.5%

-164959.3

NIFTY Performance: -9.9%

1 day Top Gainers